PSMA Targeted Therapies in Progressive Metastatic Prostate CancerModule 2 12 minutes: PSMA-PET Diagnostic Imaging in Prostate Cancer - Presented by Thomas Hope, MD Module 316 minutes: PSMA as a Therapeutic Target in Progressing Prostate Cancer - Presented by Johannes Czernin, MD 22 minutes: Discussion moderators Phillip Koo, MD, Alicia Morgans, MD, MPH, and Neal Shore, MD, FACS Biographies: Johannes Czernin, MD, Chief of the Ahmanson Translational Theranostics Division part of the UCLA Department of Molecular and Medical Pharmacology, Ronald Reagan UCLA Medical Center, Santa Monica, California.
|